Figure S1 from Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer

<p>In vitro xevinapant combination with CRT increases MOC1 tumour cell death but not in mEER.</p>

Guardado en:

Detalles Bibliográficos
Autor principal:	Charleen Chan Wah Hak (22698167) (author)
Otros Autores:	Emmanuel C. Patin (22698170) (author), Anton Patrikeev (22698173) (author), Annalisa Nicastri (22698176) (author), Zuza Kozik (22698179) (author), Holly Baldock (22698182) (author), Joan N. Kyula-Currie (15016394) (author), Victoria Roulstone (20823102) (author), Amarin Wongariyapak (22698185) (author), Valentina Gifford (22698188) (author), Tencho Tenev (22698191) (author), Elizabeth S. Appleton (22698194) (author), Lisa C. Hubbard (22698197) (author), Shane Foo (22698200) (author), Malin Pedersen (22698203) (author), Jyoti S. Choudhary (17408556) (author), Masahiro Ono (22698206) (author), Alan A. Melcher (20823117) (author), Antonio Rullan (14941920) (author), Kevin J. Harrington (17801531) (author)
Publicado:	2025
Materias:	Cancer Tumor Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Animal Models Of Cancer Head, Neck & Oral Cancers Immunology Immunomodulation Preclinical Models Radiation Oncology Combined modality therapies Tumor Microenvironment
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares